DK0812320T3 - Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse - Google Patents

Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse

Info

Publication number
DK0812320T3
DK0812320T3 DK96904993T DK96904993T DK0812320T3 DK 0812320 T3 DK0812320 T3 DK 0812320T3 DK 96904993 T DK96904993 T DK 96904993T DK 96904993 T DK96904993 T DK 96904993T DK 0812320 T3 DK0812320 T3 DK 0812320T3
Authority
DK
Denmark
Prior art keywords
pct
sec
peak
pyrethanide
amorphous
Prior art date
Application number
DK96904993T
Other languages
Danish (da)
English (en)
Inventor
Yuji Chikaraishi
Yoshihisa Matsuda
Makoto Otsuka
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03321595A external-priority patent/JP3532987B2/ja
Priority claimed from JP03321695A external-priority patent/JP3532988B2/ja
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of DK0812320T3 publication Critical patent/DK0812320T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK96904993T 1995-02-22 1996-02-12 Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse DK0812320T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP03321595A JP3532987B2 (ja) 1995-02-22 1995-02-22 新規な無晶形ピレタニドおよびその製造方法
JP03321695A JP3532988B2 (ja) 1995-02-22 1995-02-22 ピレタニドの新規な結晶多形およびその製造方法
PCT/IB1996/000254 WO1996026197A1 (fr) 1995-02-22 1996-02-12 Piretanide amorphe, polymorphes de piretanide, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
DK0812320T3 true DK0812320T3 (da) 2003-04-14

Family

ID=26371876

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904993T DK0812320T3 (da) 1995-02-22 1996-02-12 Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse

Country Status (15)

Country Link
US (1) US6096779A (fr)
EP (1) EP0812320B1 (fr)
KR (1) KR100419355B1 (fr)
CN (1) CN1072215C (fr)
AT (1) ATE194607T1 (fr)
BR (1) BR9607295A (fr)
CA (1) CA2213693C (fr)
DE (1) DE69609314T2 (fr)
DK (1) DK0812320T3 (fr)
ES (1) ES2150105T3 (fr)
GR (1) GR3034605T3 (fr)
HK (1) HK1006783A1 (fr)
MX (1) MX9706339A (fr)
PT (1) PT812320E (fr)
WO (1) WO1996026197A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
NZ536497A (en) * 2002-05-16 2006-08-31 Tibotec Pharm Ltd Pseudopolymorphic forms of a HIV protease inhibitor and their use as a medicament
EP1734931A2 (fr) * 2004-03-24 2006-12-27 Actavis Group Formulations de ramipril
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2419970C3 (de) * 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
JPS5283547A (en) * 1976-01-01 1977-07-12 Hoechst Ag Tertiary cyclic amine
DE2655331A1 (de) * 1976-12-07 1978-06-08 Hoechst Ag Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung
ES2025085B3 (es) * 1986-04-29 1992-03-16 Hoechst-Roussel Pharmaceuticals Incorporated Una estructura laminar para la administracion de un producto quimico a una velocidad de liberacion controlada.
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
JPH05230044A (ja) * 1992-02-21 1993-09-07 Hoechst Japan Ltd ピレタニドの新規な結晶多形

Also Published As

Publication number Publication date
DE69609314T2 (de) 2001-06-13
GR3034605T3 (en) 2001-01-31
KR100419355B1 (ko) 2004-06-04
KR19980702374A (ko) 1998-07-15
CN1175948A (zh) 1998-03-11
DE69609314D1 (de) 2000-08-17
CA2213693A1 (fr) 1996-08-29
BR9607295A (pt) 1997-11-25
MX9706339A (es) 1998-07-31
EP0812320A1 (fr) 1997-12-17
ES2150105T3 (es) 2000-11-16
PT812320E (pt) 2000-12-29
CN1072215C (zh) 2001-10-03
WO1996026197A1 (fr) 1996-08-29
EP0812320B1 (fr) 2000-07-12
ATE194607T1 (de) 2000-07-15
CA2213693C (fr) 2008-04-15
US6096779A (en) 2000-08-01
HK1006783A1 (en) 1999-03-19

Similar Documents

Publication Publication Date Title
JP2001520162A5 (fr)
HU9503986D0 (en) Perhydroisoindole derivatives as p substance antagonists
EG20218A (en) Process for preparing of substituted 3 aminoquinuclidines
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
CA2075173A1 (fr) Composes et methodes pour inhiber le vih et les virus associes
SE9404080D0 (sv) Förfarande för framställning av en optiskt ren enantiomer av formoterol
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
PE96999A1 (es) 1-(4-carbazoliloxi)-3-[2-(2-metoxifenoxi)etilamino]-2-propanol termodinamicamente estable, proceso para su preparacion y composiciones farmaceuticas que contienen dicho compuesto
EG19973A (en) Process for preparing of 4-aminopyridine derivatives
DK0812320T3 (da) Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse
HU9602413D0 (en) Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
AU1027992A (en) Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles, 1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
DK671588D0 (da) Bisphenylalkylpiperazinderivater og fremgangsmaade til fremstilling deraf
NO975921D0 (no) Fremstilling av bicykloheksanderivater
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
AU4442389A (en) 1,2,3,4-tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments
YU6087A (en) Process for obtaining 2-benzimidazole-ilalkylthiosulphinyl or sulphonyl derivatives
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
ES2138734T3 (es) Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona.
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
MX9703368A (es) Procedimiento para la preparacion de derivados de 1-halogeno-3-trialquilsilanil-benceno.
RU94026827A (ru) Способ получения диорганилциклосилоксанов